Bahram Valamehr is President, Chief Executive Officer and Director of Fate Therapeutics Inc (FATE). The company reported total compensation of $2,248,568 for fiscal year 2025.
| Salary | $600,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $1,283,868 |
| Non-equity incentive plan | $360,000 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $4,700 |
| Total | $2,248,568 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Fate Therapeutics Inc filed April 24, 2026, accession 0001193125-26-177094.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President, Chief Executive Officer and Director | $600,000 | $0 | $0 | $1,283,868 | $360,000 | $0 | $4,700 | $2,248,568 |
| FY2024 | President, Chief Research and Development Officer and Director | $525,000 | $147,000 | $541,000 | $2,367,000 | $0 | $0 | $4,600 | $3,584,600 |
Totals as disclosed in each year's own compensation disclosure for Fate Therapeutics Inc.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Bahram Valamehr this page | President, Chief Executive Officer and Director | $2,248,568 |
| Cindy Tahl | Chief Legal & Compliance Officer and Corporate Secretary | $1,111,996 |
| Kamal Adawi | Chief Financial Officer and Treasurer | $714,800 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Fate Therapeutics Inc compensation brief.
Bahram Valamehr's compensation sits inside Fate Therapeutics Inc's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.